Hyperthermia and the Liver

  • Anders Hugander
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 267)


The liver is the organ most commonly involved in spread of gastrointestinal cancer. Of the synchrounous liver metastas­es found at laparotomy, 20–25 % are due to colorectal cancer. Approximately 50 % of colorectal tumors will sooner or later give rise to liver metastases. The outcome for patients with primary and secondary liver cancer is dismal, with mean survival of only a few months for primary and six to eight months for secondary cancer. Liver resection may induce. a 2-year survival of approximately 30 % in patients with restricted tumor spread. These facts justify an aggressive surgical treatment in selected cases. In patients with scattered metastases in the liver dearterialization and/or chemotherapy has been used but the results are on the whole rather disappointing with a tumor response of 20–30 %. Neither dearterialization nor chemotherapy have induced any significant prolongation of survival.


Liver Tumor Hyperthermia Treatment Aggressive Surgical Treatment Liver Neoplasm Hepatic Artery Ligation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boddie AW, Booker L, Mullins JD, Buckley CJ, McBride CM., 1979, Hepatic hyperthermia by total isolation and regional perfusion in vivo. J Surg Res 26: 447 - 457.Google Scholar
  2. Bowers W, Hubbard R, Wagner D, Chrisholm P, Murphy M, Leav I, Hamlet M, Maher J., 1981, Integrity on perfused rat liver at different heat loads. Lab Invest 44: 99 - 104.Google Scholar
  3. Crile G Jr, 1961, Heat as an adjunct to the treatment of cancer: experimental studies. Cleveland Clin Quart 28: 75.Google Scholar
  4. Hafström LO, Unpublished data.Google Scholar
  5. Holmin T, Hugander A, Hägerstrand J, Ingvar C, Stridbeck H, 1987, The effect of hyperthermic ischemia on normal liver parenchyma. Eur Surg Res 19, suppl 1, 103 - 4.Google Scholar
  6. Hugander A, Hafström LO, Jönsson PE, Bolmsjö M, Persson B, Stenram U, 1984, Local hyperthermia in treatment of experimental liver tumors. Cancer 53: 1686 - 91.Google Scholar
  7. Parks LC, Minaberry D, Nely B et al, 1978, Extracorporealinduced systemic hyperthermia: effects on man and cancer. Surg Forum 29: 148 - 150.Google Scholar
  8. Petrovich Z, Langholz B, Astrahan M, Emami B, 1988, Deep microwave hyperthermia for metastatic tumors of the liver. Recent Results Cancer Res 107: 244 - 8.Google Scholar
  9. Pettigrew RT, Galt JM, Ludgate CM, Smith AN, 1974, Clinical effects of whole body hyperthermia in advanced malignancy. Brit Med J 4: 679 - 682.Google Scholar
  10. Robins HI, Hugander A, Cohen JD, 1989, Whole body hyperthermia in the treatment of neoplastic disease. Radiologic Clinics of North America Vol 27: 3, 603 - 10.Google Scholar
  11. Skibba JL, Quebbeman EJ, Kalbfleisch JH, Sonsalla JC, Petroff RJ Jr, 1986, Alterations in biochemical functions during hyperthermic isolation-perfusion of the human liver.J Surg Res 41 (4): 432 - 8.Google Scholar
  12. Storm FK, Harrisson WH, Elliott RS, Morton DL, 1979, Normal tissue and solid tumor effects of hyperthermia in animal models and clinical trials. Cancer Res 39: 2245 - 2251.Google Scholar
  13. Storm FK, Kaiser LR, Goodnight JE, Harrison WH, Elliott RS, Gomes AS, Morton DL, 1982, Thermochemotherapy for melanoma metastases in the liver. Cancer 49: 1243 - 1248.Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Anders Hugander
    • 1
  1. 1.Department of SurgeryCentral HospitalJönköpingSweden

Personalised recommendations